ReCOMmendations for the treatment of INFLUENZA
in children for Primary care physiciAnS – COMPAS INFLUENZA

Doniec, Zbigniew; Mastalerz-Migas, Agnieszka; Jackowska, Teresa; Kuchar, Ernest; Sybilski, Adam J.

doi:10.5114/fmpcr.2019.82984

Cited by 3 publications

(18 citation statements)

References 27 publications

(27 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…• Influenza is an acute infectious disease of the airways that occurs across all age groups. It may vary in severity and clinical picture -from asymptomatic to severe with symptoms of respiratory failure (1,2) . • Influenza is one of the most common acute viral respiratory infections.…”

Section: Influenza -Backgroundmentioning

confidence: 99%

See 1 more Smart Citation

Recommendations for the management of children with influenza in a primary care setting – COMPAS INFLUENZA. Update for the 2023/2024 season

Sybilski,

Mastalerz-Migas,

Jackowska

et al. 2023

Pediatr Med Rodz

Self Cite

View full text Add to dashboard Cite

Five years after publishing the first Polish recommendations on the management of influenza, especially after the COVID-19 pandemic, there was a need to update the recommendations. Influenza is an acute infectious disease of the respiratory tract that occurs in all age groups. The course of the disease may vary in severity and clinical picture, from asymptomatic to severe with symptoms of respiratory failure. The possibility of pandemic infections and serious complications distinguish influenza from other viral respiratory diseases. Diagnosis is most often clinical, and in justified cases additional tests may be helpful. The disease is characterised by a sudden onset with general symptoms such as fever, feeling cold, chills, headache, muscle and joint pain, malaise, lack of appetite and severe weakness. General symptoms are accompanied by respiratory manifestations. Physical examination shows no characteristic features. In outpatient settings during the epidemic season (October – April), the diagnosis should be made based on clinical symptoms and physical examination. Oseltamivir is recommended for both treatment and chemoprophylaxis. Clinical benefits are greatest when treatment is started as early as possible, within 48 hours of symptom onset. Clinical trials indicate that early treatment with oseltamivir may reduce both the duration of the disease and the risk of complications. Annual vaccination is the most effective method of preventing influenza, with severe anaphylactic reaction after previous vaccination being the only absolute contraindication.

show abstract

Section: Influenza -Backgroundmentioning

confidence: 99%

“…I n 2019, a team of specialists prepared and published the ReCOMmendations for the treatment of INFLUENZA in children for Primary care physiciAnS -COMPAS INFLUENZA (1) . It was the first such an extensive and comprehensive discussion on influenza in children, offering guidelines for paediatricians and family doctors.…”

Section: Introductionmentioning

confidence: 99%

Recommendations for the management of children with influenza in a primary care setting – COMPAS INFLUENZA. Update for the 2023/2024 season

Sybilski,

Mastalerz-Migas,

Jackowska

et al. 2023

Pediatr Med Rodz

Self Cite

View full text Add to dashboard Cite

show abstract

“…the respiratory syncytial virus (rsV) belongs to the Paramyxoviridae family and is responsible for human respiratory tract infections all over the world. in adults and older children, rsV infection is clinically associated with upper respiratory symptoms, while in infants, rsV causes bronchiolitis and lower respiratory tract illness that can progresses to pneumonia [31].…”

Section: Rsv Infectionsmentioning

confidence: 99%

“…interestingly, there is even data indicating that the first episode of asthma may be related to an rsV infection. in such cases, bearing in mind that rsV (and rV) infections may develop into pneumonia, respiratory disorders, apnea and, in rare cases, can lead to death, the testing for rsV infection is the decisive diagnostic element and enables the implementation of appropriate treatment [2,13,18,[31][32][33]. in the case of an infection caused by several viruses, no more severe course of the disease should be expected, since the co-infection with rsV, hrV and iV usually leads to a reduction in growth of the second virus [2,34,35].…”

Section: Rsv Infectionsmentioning

confidence: 99%

Differential diagnosis of respiratory viral infections in children in the COVID-19 pandemic time

Wawryk‐Gawda¹,

Emeryk²,

Chojęta³

2021

fmpcr

View full text Add to dashboard Cite

Background. respiratory tract infections (rtis) constitute the most common reason for pediatric patients to report to primary care facilities. additionally, rtis are also a significant problem among hospitalized patients. due to the lack of specificity in the observed symptoms, rtis cause both diagnostic and therapeutic difficulties. Objectives. the aim of our study was to explain the causes of rtis in the pediatric population and to provide guidelines to facilitate diagnosis. Material and methods. in the study, the authors analyzed available literature dealing with the possibility of laboratory diagnosis and the results of treatment used in children with rtis. Results. in pediatric patients, rtis are mainly caused by viruses and occur seasonally during the autumn-winter period. there are certain factors, such as physiological distinctness resulting from developmental immaturity of the body, genetically determined diseases and specific diseases occurring during childhood, which contribute to the incidence of rtis. moreover, factors depending on the mother and the growth environment also significantly affect the incidence of rtis in children. Conclusions. available knowledge concerning the seasonality of the occurrence of individual pathogens and the differences in symptoms may facilitate an initial diagnosis. however, lower respiratory tract infections, and severe infections in particular, require the use of specific diagnostic tests which allow for both the identification of the etiological factors and the implementation of targeted treatment. the CoVid-19 pandemic has highlighted the difficulties in the diagnosis and therapy of rtis in pediatric patients, as well as the need to develop more sensitive diagnostic tools and a more effective treatment.

show abstract

“…These are the characteristic features of the early appeared clinical symptoms by which patients start thinking of COVID-19 infection [16,18]. Anosmia and ageusia are not restricted to COVID-19 patients only because they were reported with other respiratory viral diseases such as flu (influenza) infection (Orthomyxoviruses) as well as common cold as one of the clinical symptoms [19,20]. Anosmia might be developed as a result of zinc therapy [21,22].…”

Section: Introductionmentioning

confidence: 99%

Applied Successful Treatment of Two Main Post-COVID-19 Symptoms: Anosmia and Ageusia: A Novel Approach

Mahmood¹

2021

J Inter Med Emer Res

View full text Add to dashboard Cite

Patients recovering from COVID-19 occasionally reported anosmia (loss of smell) and ageusia (loss of taste). This paper aims to use medications to treat anosmia and ageusia in post-COVD-19 recovered patients. A total of 6391 recovered COVID-19 patients were invited to enroll in this study from all age groups, both genders and different health conditions (immunocompromised and immunocompetent patients). Clinical treatments of anosmia were done by application of Apisal nasal/eye drops (Amman Pharmaceutical Industries, Jordan), used 3 times a day to stimulate nasal epithelial lining cells. It can sensitize the nose then stimulate and induce smelling function. Responders were 2794 (43.72%) of patients who were cured and retained smelling (novel work). Next was application of Vicks inhaler nasal stick which consists of 125 mg menthol, 50 mg camphor and 10 mg Siberian pine needle oil used 3 times a day. Responders were 5884 (92.07%) within 5 days. A combination of Apisal and Vicks recorded 6186 (96.80%) cures. The rest, 205 non-responsive patients to above medications were prescribed Avamys (fluticasone furoate) 27.5 micrograms/spray, nasal spray suspension (GSK, UK), twice a day which gave 203 (99.02%) cures as this is a novel work. Clinical treatment of ageusia involved administration of A-Z vital caplets (Hansal, Germany), an excellent tonic (multivitamins and minerals) once a day for adults, while Pharmaton Kiddi syrup (Boehringer Ingelheim, Germany) was given to children. Hot spices included a mixture of equal volumes of black pepper, ginger, cinnamon, cloves and coriander (doses were not determined but little mixture powder was applied inside the mouth) were advised beside tonics to stimulate taste pads so as to gain its function back to normal. 6382 (99.80%) patients got their taste back to normal within 5 days and this is also a novel work. After massive success of these medications, they were circulated all over Arab homeland as well as expat Arabs across the world.

show abstract

ReCOMmendations for the treatment of INFLUENZA in children for Primary care physiciAnS – COMPAS INFLUENZA

Cited by 3 publications

References 27 publications

Recommendations for the management of children with influenza in a primary care setting – COMPAS INFLUENZA. Update for the 2023/2024 season

Recommendations for the management of children with influenza in a primary care setting – COMPAS INFLUENZA. Update for the 2023/2024 season

Differential diagnosis of respiratory viral infections in children in the COVID-19 pandemic time

Applied Successful Treatment of Two Main Post-COVID-19 Symptoms: Anosmia and Ageusia: A Novel Approach

Contact Info

Product

Resources

About